The sales of antiinfective medicines in Germany demonstrated significant fluctuations between 2013 and 2023. Starting at 7.6 units in 2013, the market saw a peak in 2015 with 10.6 units, followed by a decline to 4.9 units in 2021. Notably, sales increased by 16.33% in 2022 to 5.7 units and by 1.75% in 2023, reaching 5.8 units. From 2019 to 2023, the Compound Annual Growth Rate (CAGR) was -2.55%, indicating a general downward trend.

Future trends to watch for:

A forecasted stabilization in the market with a CAGR of 0.34% from 2024 to 2028.
Potential impacts of emerging infectious diseases and new treatment protocols.
Regulatory changes and advancements in antiinfective drug development.